Clinical Trial Update: Seasonal Malaria Chemoprevention With Dihydroartemisin Piperaquin vs. Sulfadoxine-pyrimethamin+Amodiaquin [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine+amodiaquine for seasonal malaria chemoprevention in falciparum ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria
• Malaria

Drugs mentioned

• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)
• sulfadoxine-pyrimethamine + amodiaquine (sulfadoxine-pyrimethamine and amodiaquine)

Snippet

Sponsor: University Clinical Research Center, Mali | Conditions: Malaria,Falciparum | Phase 3 | Status: UNKNOWN